DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 04 · Volume 49 · July 2016 DOI: 10.1055/s-006-32037

Review

  • 137
    Mutschler, J.; Grosshans, M.; Soyka, M.; Rösner, S.:

    Current Findings and Mechanisms of Action of Disulfiram in the Treatment of Alcohol Dependence

    • Original Paper

  • 142
    Inta, I.; Bettendorf, M.; Gass, P.:

    Conserved Hypothalamic c-Fos Activation Pattern Induced by the mGlu5 Receptor Antagonist MPEP during Peri-pubertal Development in Mice

  • 146
    Kittel-Schneider, S.; Spiegel, S.; Renner, T.; Romanos, M.; Reif, A.; Reichert, S.; Heupel, J.; Schnetzler, L.; Stopper, H.; Jacob, C.:

    Cytogenetic Effects of Chronic Methylphenidate Treatment and Chronic Social Stress in Adults with Attention-Deficit/Hyperactivity Disorder

    Supporting Information (PDF)
  • 155
    Schjerning, O.; Pottegård, A.; Damkier, P.; Rosenzweig, M.; Nielsen, J.:

    Use of Pregabalin – A Nationwide Pharmacoepidemiological Drug Utilization Study with Focus on Abuse Potential

  • 162
    Nikbakhat, M.-R.; Arabzadeh, S.; Zeinoddini, A.; Khalili, Z.; Rezaei, F.; Mohammadinejad, P.; Ghaleiha, A.; Akhondzadeh, S.:

    Duloxetine Add-On to Risperidone for Treatment of Negative Symptoms in Patients with Stable Schizophrenia: Randomized Double-Blind Placebo-Controlled Study

  • 170
    Müller, U. J.; Sturm, V.; Voges, J.; Heinze, H.-J.; Galazky, I.; Büntjen, L.; Heldmann, M.; Frodl, T.; Steiner, J.; Bogerts, B.:

    Nucleus Accumbens Deep Brain Stimulation for Alcohol Addiction – Safety and Clinical Long-term Results of a Pilot Trial